Global Biosimilar Monoclonal Antibodies Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 11-May-2023
No. of pages: 126

The Biosimilar Monoclonal Antibodies market revenue was 5156.19 Million USD in 2022, and will reach 14274.14 Million USD in 2028, with a CAGR of 18.5% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the Biosimilar Monoclonal Antibodies industry, and breaks down according to the type, application, and consumption area of Biosimilar Monoclonal Antibodies. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Biosimilar Monoclonal Antibodies in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the Biosimilar Monoclonal Antibodies market covered in Chapter 11:

Sandoz

Boehringer Ingelheim

Dr Reddy's

Samsung

Shanghai CP Guojian Pharmaceutical

Hospira

Amgen

Celltrion

Zydus

In Chapter 3, on the basis of types, the Biosimilar Monoclonal Antibodies market from 2018 to 2028 is primarily split into:

Infliximab

Rituximab

Trastuzumab

Adalimumab

Other

In Chapter 4, on the basis of applications, the Biosimilar Monoclonal Antibodies market from 2018 to 2028 covers:

Oncology

Autoimmune Disease

Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Biosimilar Monoclonal Antibodies Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Biosimilar Monoclonal Antibodies Market, By Product Type
3.1 Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Biosimilar Monoclonal Antibodies Sales and Market Share by Types (2018-2023)
3.1.2 Biosimilar Monoclonal Antibodies Revenue and Market Share by Types (2018-2023)
3.1.3 Biosimilar Monoclonal Antibodies Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Biosimilar Monoclonal Antibodies Sales, Price and Growth Rate of Infliximab (2018-2023)
3.4 Biosimilar Monoclonal Antibodies Sales, Price and Growth Rate of Rituximab (2018-2023)
3.5 Biosimilar Monoclonal Antibodies Sales, Price and Growth Rate of Trastuzumab (2018-2023)
3.6 Biosimilar Monoclonal Antibodies Sales, Price and Growth Rate of Adalimumab (2018-2023)
3.7 Biosimilar Monoclonal Antibodies Sales, Price and Growth Rate of Other (2018-2023)

4 Biosimilar Monoclonal Antibodies Market, By Applications
4.1 Biosimilar Monoclonal Antibodies Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Biosimilar Monoclonal Antibodies Consumption and Market Share by Applications (2018-2023)
4.1.2 Biosimilar Monoclonal Antibodies Revenue and Market Share by Applications (2018-2023)
4.2 Oncology
4.3 Autoimmune Disease
4.4 Other

5 Biosimilar Monoclonal Antibodies Market, By Regions
5.1 Biosimilar Monoclonal Antibodies Market Sales and Market Share by Regions
5.1.1 Biosimilar Monoclonal Antibodies Sales by Regions (2018-2023)
5.1.2 Biosimilar Monoclonal Antibodies Sales Market Share by Regions (2018-2023)
5.2 Biosimilar Monoclonal Antibodies Market Revenue and Market Share by Regions
5.2.1 Biosimilar Monoclonal Antibodies Revenue by Regions (2018-2023)
5.2.2 Biosimilar Monoclonal Antibodies Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America Biosimilar Monoclonal Antibodies Market Analysis
6.1 North America Biosimilar Monoclonal Antibodies Market Size
6.1.1 North America Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
6.1.2 North America Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Biosimilar Monoclonal Antibodies Market Size
6.3 Canada Biosimilar Monoclonal Antibodies Market Size
6.4 Mexico Biosimilar Monoclonal Antibodies Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe Biosimilar Monoclonal Antibodies Market Analysis
7.1 Europe Biosimilar Monoclonal Antibodies Market Size
7.1.1 Europe Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
7.2 Germany Biosimilar Monoclonal Antibodies Market Size
7.3 United Kingdom Biosimilar Monoclonal Antibodies Market Size
7.4 France Biosimilar Monoclonal Antibodies Market Size
7.5 Italy Biosimilar Monoclonal Antibodies Market Size
7.6 Spain Biosimilar Monoclonal Antibodies Market Size
7.7 Russia Biosimilar Monoclonal Antibodies Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific Biosimilar Monoclonal Antibodies Market Analysis
8.1 Asia-Pacific Biosimilar Monoclonal Antibodies Market Size
8.1.1 Asia-Pacific Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
8.2 China Biosimilar Monoclonal Antibodies Market Size
8.3 Japan Biosimilar Monoclonal Antibodies Market Size
8.4 South Korea Biosimilar Monoclonal Antibodies Market Size
8.5 Australia Biosimilar Monoclonal Antibodies Market Size
8.6 India Biosimilar Monoclonal Antibodies Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa Biosimilar Monoclonal Antibodies Market Analysis
9.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size
9.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Biosimilar Monoclonal Antibodies Market Size
9.3 UAE Biosimilar Monoclonal Antibodies Market Size
9.4 Egypt Biosimilar Monoclonal Antibodies Market Size
9.5 South Africa Biosimilar Monoclonal Antibodies Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America Biosimilar Monoclonal Antibodies Market Analysis
10.1 South America Biosimilar Monoclonal Antibodies Market Size
10.1.1 South America Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
10.1.2 South America Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Biosimilar Monoclonal Antibodies Market Size
10.3 Argentina Biosimilar Monoclonal Antibodies Market Size
10.4 Columbia Biosimilar Monoclonal Antibodies Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 Sandoz
11.1.1 Sandoz Basic Information
11.1.2 Sandoz Product Profiles, Application and Specification
11.1.3 Sandoz Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Basic Information
11.2.2 Boehringer Ingelheim Product Profiles, Application and Specification
11.2.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.3 Dr Reddy's
11.3.1 Dr Reddy's Basic Information
11.3.2 Dr Reddy's Product Profiles, Application and Specification
11.3.3 Dr Reddy's Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.4 Samsung
11.4.1 Samsung Basic Information
11.4.2 Samsung Product Profiles, Application and Specification
11.4.3 Samsung Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.5 Shanghai CP Guojian Pharmaceutical
11.5.1 Shanghai CP Guojian Pharmaceutical Basic Information
11.5.2 Shanghai CP Guojian Pharmaceutical Product Profiles, Application and Specification
11.5.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.6 Hospira
11.6.1 Hospira Basic Information
11.6.2 Hospira Product Profiles, Application and Specification
11.6.3 Hospira Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.7 Amgen
11.7.1 Amgen Basic Information
11.7.2 Amgen Product Profiles, Application and Specification
11.7.3 Amgen Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.8 Celltrion
11.8.1 Celltrion Basic Information
11.8.2 Celltrion Product Profiles, Application and Specification
11.8.3 Celltrion Biosimilar Monoclonal Antibodies Market Performance (2018-2023)
11.9 Zydus
11.9.1 Zydus Basic Information
11.9.2 Zydus Product Profiles, Application and Specification
11.9.3 Zydus Biosimilar Monoclonal Antibodies Market Performance (2018-2023)

12 Biosimilar Monoclonal Antibodies Market Forecast, By Type and Applications
12.1 Biosimilar Monoclonal Antibodies Market Forecast by Types (2023-2028)
12.1.1 Biosimilar Monoclonal Antibodies Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Biosimilar Monoclonal Antibodies Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Biosimilar Monoclonal Antibodies Market Forecast by Applications (2023-2028)
12.2.1 Biosimilar Monoclonal Antibodies Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Biosimilar Monoclonal Antibodies Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Biosimilar Monoclonal Antibodies Market Forecast, By Regions
13.1 Biosimilar Monoclonal Antibodies Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Biosimilar Monoclonal Antibodies Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Biosimilar Monoclonal Antibodies Market Forecast (2023-2028)
13.4 Europe Biosimilar Monoclonal Antibodies Market Forecast (2023-2028)
13.5 Asia-Pacific Biosimilar Monoclonal Antibodies Market Forecast (2023-2028)
13.6 Middle East and Africa Biosimilar Monoclonal Antibodies Market Forecast (2023-2028)
13.7 South America Biosimilar Monoclonal Antibodies Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table Biosimilar Monoclonal Antibodies Key Market Segments
Figure Biosimilar Monoclonal Antibodies Market Size and Growth Rate 2018-2028
Figure Channel Status of Biosimilar Monoclonal Antibodies
Table Market Driving Factors of Biosimilar Monoclonal Antibodies
Table Market Industry Constraints and Challenges of Biosimilar Monoclonal Antibodies
Figure COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Biosimilar Monoclonal Antibodies Sales by Types (2018-2023)
Table Biosimilar Monoclonal Antibodies Sales Share by Types (2018-2023)
Table Biosimilar Monoclonal Antibodies Revenue ($) by Types (2018-2023)
Table Biosimilar Monoclonal Antibodies Revenue Share by Types (2018-2023)
Table Biosimilar Monoclonal Antibodies Price by Types (2018-2023)
Figure Infliximab Sales and Growth Rate (2018-2023)
Figure Infliximab Price (2018-2023)
Figure Rituximab Sales and Growth Rate (2018-2023)
Figure Rituximab Price (2018-2023)
Figure Trastuzumab Sales and Growth Rate (2018-2023)
Figure Trastuzumab Price (2018-2023)
Figure Adalimumab Sales and Growth Rate (2018-2023)
Figure Adalimumab Price (2018-2023)
Figure Other Sales and Growth Rate (2018-2023)
Figure Other Price (2018-2023)
Table Biosimilar Monoclonal Antibodies Consumption by Applications (2018-2023)
Table Biosimilar Monoclonal Antibodies Consumption Share by Applications (2018-2023)
Table Biosimilar Monoclonal Antibodies Revenue ($) by Applications (2018-2023)
Table Biosimilar Monoclonal Antibodies Revenue Share by Applications (2018-2023)
Figure Oncology Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Autoimmune Disease Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Other Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Biosimilar Monoclonal Antibodies Sales and Growth Rate (2018-2023)
Table Biosimilar Monoclonal Antibodies Sales by Regions (2018-2023)
Table Biosimilar Monoclonal Antibodies Sales Market Share by Regions (2018-2023)
Figure Biosimilar Monoclonal Antibodies Sales Market Share by Regions in 2022
Figure Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2018-2023)
Table Biosimilar Monoclonal Antibodies Revenue by Regions (2018-2023)
Table Biosimilar Monoclonal Antibodies Revenue Market Share by Regions (2018-2023)
Figure Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2022
Figure North America Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Table North America Biosimilar Monoclonal Antibodies Sales by Countries (2018-2023)
Figure North America Biosimilar Monoclonal Antibodies Market Revenue ($) and Growth Rate (2018-2023)
Table North America Biosimilar Monoclonal Antibodies Revenue ($) by Countries (2018-2023)
Figure U.S. Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure U.S. Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Canada Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Canada Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Mexico Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Table Europe Biosimilar Monoclonal Antibodies Sales by Countries (2018-2023)
Figure Europe Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Table Europe Biosimilar Monoclonal Antibodies Revenue by Countries (2018-2023)
Figure Germany Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Germany Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure France Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure France Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Italy Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Italy Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Spain Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Spain Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Russia Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Russia Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Countries (2018-2023)
Figure Asia-Pacific Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Countries (2018-2023)
Figure China Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure China Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Japan Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Japan Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure South Korea Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure South Korea Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Australia Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Australia Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure India Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure India Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Countries (2018-2023)
Figure Middle East and Africa Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Countries (2018-2023)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure UAE Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure UAE Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Egypt Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Egypt Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure South Africa Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure South Africa Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure South America Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Table South America Biosimilar Monoclonal Antibodies Sales by Countries (2018-2023)
Figure South America Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Table South America Biosimilar Monoclonal Antibodies Revenue by Countries (2018-2023)
Figure Brazil Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Brazil Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Argentina Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Argentina Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Figure Columbia Biosimilar Monoclonal Antibodies Market Sales and Growth Rate (2018-2023)
Figure Columbia Biosimilar Monoclonal Antibodies Market Revenue and Growth Rate (2018-2023)
Table Sandoz Company Profile
Table Sandoz Production, Value, Price, Gross Margin 2018-2023
Figure Sandoz Production and Growth Rate
Figure Sandoz Value ($) Market Share 2018-2023
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2018-2023
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2018-2023
Table Dr Reddy's Company Profile
Table Dr Reddy's Production, Value, Price, Gross Margin 2018-2023
Figure Dr Reddy's Production and Growth Rate
Figure Dr Reddy's Value ($) Market Share 2018-2023
Table Samsung Company Profile
Table Samsung Production, Value, Price, Gross Margin 2018-2023
Figure Samsung Production and Growth Rate
Figure Samsung Value ($) Market Share 2018-2023
Table Shanghai CP Guojian Pharmaceutical Company Profile
Table Shanghai CP Guojian Pharmaceutical Production, Value, Price, Gross Margin 2018-2023
Figure Shanghai CP Guojian Pharmaceutical Production and Growth Rate
Figure Shanghai CP Guojian Pharmaceutical Value ($) Market Share 2018-2023
Table Hospira Company Profile
Table Hospira Production, Value, Price, Gross Margin 2018-2023
Figure Hospira Production and Growth Rate
Figure Hospira Value ($) Market Share 2018-2023
Table Amgen Company Profile
Table Amgen Production, Value, Price, Gross Margin 2018-2023
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2018-2023
Table Celltrion Company Profile
Table Celltrion Production, Value, Price, Gross Margin 2018-2023
Figure Celltrion Production and Growth Rate
Figure Celltrion Value ($) Market Share 2018-2023
Table Zydus Company Profile
Table Zydus Production, Value, Price, Gross Margin 2018-2023
Figure Zydus Production and Growth Rate
Figure Zydus Value ($) Market Share 2018-2023
Table Biosimilar Monoclonal Antibodies Market Forecast Sales by Types (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Sales Share by Types (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Revenue ($) by Types (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Revenue Share by Types (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Consumption by Applications (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Consumption Share by Applications (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Revenue ($) by Applications (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Revenue Share by Applications (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Sales by Regions (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Sales Share by Regions (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Revenue ($) by Regions (2023-2028)
Table Biosimilar Monoclonal Antibodies Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Biosimilar Monoclonal Antibodies Market Insights, Forecast to 2029
    Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 88
    Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufacture......
  • Global Biologics and Biosimilars Market Insights, Forecast to 2029
    Published: 22-Sep-2023        Price: US 4900 Onwards        Pages: 115
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactu......
  • Global Biologics and Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Sep-2023        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Biologics and Biosimilars market: According to our latest research, the global Biologics and Biosimilars market looks promising in the next 5 years. As of 2022, the global Biologics and Biosimilars market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Biosimilars are biomedical products that are almost identical to the original products made by different companies. ......
  • Global Biosimilar Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 01-Aug-2023        Price: US 3260 Onwards        Pages: 125
    Biosimilar therapy is defined as a therapy that is highly similar to approved biopharmaceuticals. They are made by converting biopharmaceuticals made from living cells in the laboratory into large-scale production molecules. This is quite different from the general treatment method, which is identical to the reference small molecule drug. The reason behind this is that it is impossible to make a copy of the same biologic drug. The Biosimilar Drug market revenue was 16199.84 Million USD in......
  • Global Oncology Biosimilars Market Insights, Forecast to 2029
    Published: 07-Jul-2023        Price: US 4900 Onwards        Pages: 110
    Biosimilar is the identical copy of oncology biologics used for the treatment of cancer and officially approved for the treatment of cancer. These molecules are cost-effective, efficient, and have the same ability as biologics. These molecules are easy to manufacture as compared to biologics and can only be manufactured after patent expiry. Earlier there were various patented biologics available in the market but nowadays most of the patents have expired and few are on the verge of patent expiry......
  • Global Adalimumab Biosimilar Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 04-Jul-2023        Price: US 3260 Onwards        Pages: 125
    Adalimumab was a first fully humanized monoclonal antibody approved by US Food and Drug Administration (FDA) in 2002. Clinical efficacy and safety of adalimumab has been assessed in various trials in rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. It is one of the major sales success among biological and still one of the greatest blockbuster amongst monoclonal antibodies. The Adalimumab Biosimilar market revenue was 2......
  • Global Follow-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 114
    The Follow-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Follow-On-Biologics industry, and breaks down according to the type, application, and consumption area of Follow-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describe......
  • Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region - Global Forecast to 2028
    Published: 15-Jun-2023        Price: US 4950 Onwards        Pages: 306
    “The biosimilars market is projected to grow at a CAGR of 17.8% during the forecast of 2023-2028” The global biosimilars market size is projected to reach USD 66.9 billion by 2028 from USD 29.4 billion in 2023, at a CAGR of 17.8% during the forecast period. Factors such as regulatory approvals, favorable reimbursement policies, rising demand for cost effective biosimilars is driving the market growth. “The monoclonal antibodies produc......
  • Global Biosimilars-On-Biologics Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 06-Jun-2023        Price: US 3260 Onwards        Pages: 130
    The Biosimilars-On-Biologics market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Biosimilars-On-Biologics industry, and breaks down according to the type, application, and consumption area of Biosimilars-On-Biologics. The report also introduces players in the industry from the perspective of the industry chain and marketing cha......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs